Surgical Outcome after Sleeve Pneumonectomy for Thoracic Malignancy: A Comparison Between Salvage and Non-salvage

DOI Web Site Web Site 参考文献15件
  • IMASHIMIZU KOTA
    Department of General Thoracic Surgery, Juntendo University School of Medicine
  • SUZUKI KENJI
    Department of General Thoracic Surgery, Juntendo University School of Medicine
  • UCHIDA SHINSUKE
    Department of General Thoracic Surgery, Juntendo University School of Medicine
  • FUKUI MARIKO
    Department of General Thoracic Surgery, Juntendo University School of Medicine
  • HATTORI ARITOSHI
    Department of General Thoracic Surgery, Juntendo University School of Medicine
  • MATSUNAGA TAKESHI
    Department of General Thoracic Surgery, Juntendo University School of Medicine
  • OH SHIAKI
    Department of General Thoracic Surgery, Juntendo University School of Medicine
  • TAKAMOCHI KAZUYA
    Department of General Thoracic Surgery, Juntendo University School of Medicine

この論文をさがす

説明

<p>Objectives Tumors invading the tracheobronchial angle or carina have long presented a challenge due to the complexity of airway reconstruction and management; thus, few medical centers have developed experience with this type of surgery. In this report, we review our experience with Sleeve Pneumonectomy (SP) and analyze both operative risks and outcomes.</p><p>Materials and Methods A retrospective review identified 34 patients who underwent SP: 19 underwent salvage SP and 15 underwent non-salvage SP. Salvage surgery was performed for recurrent lung cancer after chemoradiotherapy and could be considered if there were no other therapeutic options or in the presence of urgent symptoms, such as hemoptysis, obstructive pneumonia, superior vena cava syndrome, or tracheoesophageal fistula. The perioperative morbidity and oncological outcomes of salvage and non-salvage SP were analyzed.</p><p>Results Most cases were of lung cancer, whereas salvage SP included one case of SVC syndrome due to metastasis of colon cancer and one case of hemoptysis due to metastasis of leiomyosarcoma. Complications occurred in 47% of the non-salvage SP cases and 53% of the salvage SP cases. The 30-day mortality rates were zero in the non-salvage cases and 11% in the salvage cases. The 90-day mortality rates were 20% and 16% in the non-salvage and salvage groups, respectively.</p><p>Conclusions The salvage of SP after chemoradiotherapy or in the presence of urgent symptoms is feasible. We believe that it can be an option that improves quality of life (QOL) through longer desease-free survival (DFS) and alleviation of symptoms, rather than waiting for tumor growth progression and exacerbation of symptoms.</p>

収録刊行物

参考文献 (15)*注記

もっと見る

キーワード

詳細情報 詳細情報について

問題の指摘

ページトップへ